ALDR - Alder Biopharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ALDR (1423824)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
27 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S12+0-1-11-32

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-09-04
ALDRSmith Jeffrey T LMDS - Sale+OE$18.00-5,040831-86%-$90,699
D
2018-09-04
ALDRLatham John AChief Scientific OfficerS - Sale+OE$17.99-24,999243,693-9%-$449,680
D
2018-08-01
ALDRSmith Jeffrey T LMDS - Sale+OE$19.54-5,040831-86%-$98,489
D
2018-08-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$19.55-24,999243,693-9%-$488,768
D
2018-07-02
ALDRSmith Jeffrey T LMDS - Sale+OE$15.49-12,161831-94%-$188,364
D
2018-07-02
ALDRLatham John AChief Scientific OfficerS - Sale+OE$15.48-24,999243,693-9%-$387,002
D
2018-06-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$17.86-24,999243,693-9%-$446,356
D
2018-06-01
ALDRSmith Jeffrey T LMDS - Sale+OE$17.85-12,161831-94%-$217,127
D
2018-06-01
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$17.84-22,727180,189-11%-$405,412
D
2018-05-16
ALDRSmith Jeffrey T LMDS - Sale+OE$15.03-12,161831-94%-$182,758
D
2017-11-13
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$10.80-16,519177,932-8%-$178,486
D
2017-10-16
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$12.33-16,520177,932-8%-$203,703
2017-07-18
ALDRYarno Wendy LDirP - Purchase$10.00+5,0005,000New+$50,000
2017-07-18
ALDRDow Stephen MDirP - Purchase$10.00+25,000307,190+9%+$250,000
D
2017-06-20
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$20.00-585831-41%-$11,700
D
2017-02-09
ALDRSchatzman Randall CPres, CEOS - Sale+OE$25.03-30,000115,172-21%-$750,7560-3-5
D
2017-01-18
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$23.10-1,498177,932-1%-$34,599-4-5+11
DM
2017-01-05
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$23.01-9,516177,932-5%-$218,9920-4+4
D
2016-12-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$22.78-3,000831-78%-$68,328+1-5-4
D
2016-12-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$22.78-3,636242,403-1%-$82,812+1-5-4
D
2016-11-09
ALDRLatham John AChief Scientific OfficerS - Sale+OE$30.18-10,000242,200-4%-$301,839-3-17-37
D
2016-11-07
ALDRSchatzman Randall CPres, CEOS - Sale+OE$25.16-10,000114,768-8%-$251,605+3+14-31-41
D
2016-11-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$24.34-3,0000-100%-$73,032+8+30+2-7
2016-10-17
ALDRLitton Mark JamesChief Business OfficerS - Sale$27.50-6,000125,567-5%-$164,998+70+5-26
D
2016-10-03
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$31.14-3,0000-100%-$93,415-4-4-25-39
D
2016-10-03
ALDRSchatzman Randall CPres, CEOS - Sale+OE$31.15-8,181114,768-7%-$254,811-4-4-25-39
D
2016-10-03
ALDRLatham John AChief Scientific OfficerS - Sale+OE$31.32-10,000242,200-4%-$313,152-4-4-25-39
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top